Congruence Therapeutics operates as a biotechnology company.
Congruence Therapeutics has raised $39.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2026.
Congruence Therapeutics's investors include OrbiMed, Lumira Ventures, Fonds de solidarité FTQ, BDC Venture Capital, Dimension Capital.
Congruence Therapeutics is headquartered in Montréal, Canada.
Congruence Therapeutics operates as a biotechnology company.
Congruence Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Congruence Therapeutics — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/congruence-therapeutics. Accessed August 6, 2026.
VCBacked. (2026). Congruence Therapeutics — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/congruence-therapeutics
{{cite web |title=Congruence Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/congruence-therapeutics |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated